The Rao Lab Presents New Work on Vitreoretinal Lymphoma at The Macula Society
Post date: Apr 15, 2018 5:29:13 PM
At the 41st Annual Meeting of The Macula Society at the Beverly Hilton in Los Angeles, The Rao Lab shared its newest disease-related research. On February 24, 2018 we showed our data that lymphoma of the retina and vitreous is genetically distinct from primary CNS lymphoma. This is surprising because vitreoretinal lymphoma and CNS lymphoma are most conventionally considered to be different sites of the same cancer. Our collaboration with the Tomlins Lab at University of Michigan has revealed the actionable cancer genome for this cancer for the first time as well as novel, druggable genetic alterations. It was great to catch up with mentors and old friends, and meet new ones! Rajesh C. Rao, M.D. is the youngest member elected to The Macula Society, since its founding in 1977.